PPT-Renal transplantation

Outline Basics of transplantation Benefits of transplantation Immunosuppressive medications Common posttransplant problems Basics of Transplantation Kidney transplantation is the most effective therapy for endstage renal disease. Thea Brennan-Krohn (“BK”). July 2010. Polyomaviruses. Small DS DNA viruses. Cause “poly” “. omas. ”. Non-human . polyomaviruses. :. Murine. K . virus, discovered 1952 [1]. Simian virus 40 (SV40. Kiran Babu, Fellow. UTHSC. 1/17/2012. BK Virus Nephropathy. Introduction. Virology. Epidemiology. Pathogenesis. Diagnosis, Risk factors & screening. Treatment. Trends. BKV was first isolated in 1970 from a Sudanese kidney transplant recipient with . Prof Paul A . Corris. Newcastle University. Newcastle Upon Tyne. Pulmonary Hypertension. Which of the following statements are true. A breathless patient with normal LV systolic function and whose RHC results show a mean PAP of 30 mmHg and a PCW of 23 mmHg has pulmonary arterial hypertension. Cardiac : Eligibility and Listing Criteria in Canada 2012 1 Cardiac Transplantation: Eligibility and Listing Criteria in Canada Debra Isaac MD, Michael Chan MD, Haissam Haddad MD, Anson Cheung MD, Elena Levtchenko University Hospitals Leuven, Belgium April 30, 2019 Disclosures E. Levtchenko performs consultancy for Orphan Europe, Chiesi , Kyowa Kirin, Advicenne and was supported by a resear This copy is uncontrolled unless printed on ‘Controlled’ paper(Template Version 07/10/08) Author(s): Kathy Zalewska Page 1 of 24 This Policy replacesPOL195/Copy Number Summary of Significa Kerry Tomlinson on behalf of sponsor group . UKKW 2017. . . C. ontent. Background. Is it working. What we did. Lessons learnt. Next steps and KQUIP roll out . Background: identifying the problem. UK RR 2014 report median time to listing. The patient is a 41 year-old male who has a longstanding history of hypertension and diabetes and presents with a complaint of . pruritis. , lethargy, lower extremity edema, nausea and emesis. He denies any other medical illnesses.. . Is . transplantation a final end, or a new start?. 10302010078 . Liu . Wangyuan. Key Words. Allograft: . grafts transplanted between individuals of the same species. MHC:. major histocompatibility complex. I. PAÚ. Transplantation. Transfer . of. . living. . tissue. . Cells. : stem . cells. , . blood. . cells. – . platelets. , …. Tissue. : . blood. , bone . marrow. , skin, bone, . cartilage. , . DR. Prof. D. K. AGARWAL. MD,DM,DNB,MAMS,FICP,FISN. Senior Consultant . Nephrologist. ,. Indraprastha Apollo Hospitals,. New Delhi. Phone: Mobile: +91-98112 00113 e-mail: dmas100@gmail.com . Presented by. Rama . Shukla. Assistant Professor. LNCP,BHOPAL. Dr Jean . Filipov. , PhD. UH . Alexandrovska. Sofia, Bulgaria. Plan of the presentation. Biochemical abnormalities after kidney transplantation (KT). Bone disease after KT. Vascular involvement after KT. Tenofovir. . Disoproxil. . Fumarate. to . Tenofovir. . Alafenamide. Have Improved Renal and Bone Safety through 48 Weeks. Study GS-US-292-0112. Samir K. Gupta. 1. , Anton Pozniak. 2. , Jose Arribas.